Patent details

EP3411411 Title: 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS

Basic Information

Publication number:
EP3411411
PCT Application Number:
US2017015953
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177480449
PCT Publication Number:
WO2017136395
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS
French Title of Invention:
DÉRIVÉS DE 1H-INDAZOLE-3-CARBOXAMIDE ET COMPOSÉS SIMILAIRES EN TANT QU'INHIBITEURS DU FACTEUR D POUR LE TRAITEMENT DE MALADIES CHARACTERISÉS PAR UNE ACTIVITÉ ABERRANTE DU SYSTÈME COMPLÉMENTAIRE, COMME P.E. TROUBLES IMMUNOLOGIQUES
German Title of Invention:
1H-INDAZOL-3-CARBOXAMID-DERIVATE UND ÄHNLICHE VERBINDUNGE ALS FAKTOR D INHIBITOREN ZUR BEHANDLUNG VON DURCH EINE ABERRANTE AKTIVITÄT DES KOMPLEMENTSYSTEMS GEKENNZEICHNET ERKRANKUNGEN, WIE Z.B. IMMUNOLOGISCHE STÖRUNGEN
SPC Number:

Dates

Filing date:
01/02/2017
Grant date:
19/05/2021
EP Publication Date:
12/12/2018
PCT Publication Date:
10/08/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/05/2021
EP B1 Publication Date:
19/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
26/01/2022
Lapsed date:
Expiration date:
01/02/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/01/2022
 
 

Name:
Biocryst Pharmaceuticals, Inc.
Address:
4505 Emperor Blvd., Durham, North Carolina 27703, United States (US)

Agent

Name:
STOLMÁR & PARTNER
From:
30/06/2021
Address:
BLUMENSTR. 17, 80331, MÜNCHEN, Germany (DE)
To:

Inventor

1

Name:
RAMAN, Krishnan
Address:
United States (US)

2

Name:
ZHANG, Weihe
Address:
United States (US)

3

Name:
BABU, Yarlagadda, S.
Address:
United States (US)

4

Name:
WU, Minwan
Address:
United States (US)

5

Name:
CHINTAREDDY, Venkat, R.
Address:
United States (US)

6

Name:
VOGETI, Lakshminarayana
Address:
United States (US)

7

Name:
KOTIAN, Pravin, L.
Address:
United States (US)

Priority

Priority Number:
201662289653 P
Priority Date:
01/02/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07D 401/12; C07D 231/56; C07D 209/40; C07D 209/42; C07D 209/48; C07D 487/04; C07D 471/04; C07D 403/12; C07D 403/04; C07D 403/06; A61K 31/416; A61K 31/4439; A61K 31/404; A61K 31/4035; A61P 37/00; A61P 37/06; A61P 25/00; A61P 25/28; A61P 13/12; A61P 9/00; A61P 21/04; C07D 401/04; C07D 401/06; C07D 401/14; C07D 405/12; C07D 209/12; A61P 13/00;

Publication

European Patent Bulletin

1

Issue number:
202120
Publication date:
19/05/2021
Description:
Grant (B1)

2

Issue number:
202129
Publication date:
21/07/2021
Description:
Request for limitation Filed (Art.105a)

3

Issue number:
202147
Publication date:
24/11/2021
Description:
Request for limitation of patent allowed

4

Issue number:
202204
Publication date:
26/01/2022
Description:
Limited Patent Specification (B3)

5

Issue number:
202147
Publication date:
24/11/2021
Description:
International Patent Classification Changed

6

Issue number:
202147
Publication date:
24/11/2021
Description:
Title of invention Modified

7

Issue number:
202125
Publication date:
23/06/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/03/2027
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/01/2026
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
SUN IP LLC
Filing date Document type Number of pages
30/06/2021 Power Of Attorney 2
30/06/2021 Outgoing Correspondence 1